Molecular and Cellular Biochemistry

, Volume 452, Issue 1–2, pp 71–82 | Cite as

Molecular changes to the rat renal cotransporters PEPT1 and PEPT2 due to ageing

  • Othman A. Alghamdi
  • Nicola KingEmail author
  • Nicholas M. Andronicos
  • Graham L. Jones
  • Belal Chami
  • Paul K. Witting
  • Pierre D. J. Moens


Renal PEPT1 and PEPT2 cotransporters play an important role in the balance of circulating body oligopeptides and selected peptidomimetic drugs. We aim to comprehensively characterise age-related changes of the renal PEPT cotransporters at the gene, protein, and functional level. Brush border membrane vesicles (BBMV) and outer medulla membrane vesicles (OMMV) were isolated from the kidneys of young, middle-aged and old rats. The protein expression of PEPT1 was not only increased in BBMV from old rats, but PEPT1 also appeared in OMMV from middle-aged and old rats. SLC15A1 gene expression in the renal cortex increased in middle-aged group. PEPT2 protein expression was not only increased with ageing, but PEPT2 also was found in BBMV from middle-aged and old groups. SLC15A2 gene expression in the renal outer medulla increased in the old group. These changes in the expressions and localisations of PEPT1 and PEPT2 could explain the changes to transport activity in BBMV and OMMV. These findings provide novel insights that would be useful for maintaining protein nutrition and optimising the delivery of some peptidomimetic drugs in elderly individuals.


Ageing Oligopeptide transport PEPT1 PEPT2 Kidney 



We would like to thank Mr. Brian Cross and Mr. Jonathon Clay for their excellent technical assistance. This work was supported by University of New England (unnumbered grant), Australian Research Council (DP160102063) and University of Jeddah (Unnumbered Grant).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All applicable international, national and/or institutional guidelines for the care and use of animals were followed.

Supplementary material

11010_2018_3413_MOESM1_ESM.docx (280 kb)
Supplementary material 1 (DOCX 280 KB)


  1. 1.
    Shi S, Morike K, Klotz U (2008) The clinical implications of ageing for rational drug therapy. Eur J Clin Pharmacol 64:183–199CrossRefGoogle Scholar
  2. 2.
    Mangoni AA, Jackson SH (2004) Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 57:6–14CrossRefGoogle Scholar
  3. 3.
    Aalami OO, Fang TD, Song HM, Nacamuli RP (2003) Physiological features of aging persons. Arch Surg 138:1068–1076CrossRefGoogle Scholar
  4. 4.
    Martin JE, Sheaff MT (2007) Renal ageing. J Pathol 211:198–205CrossRefGoogle Scholar
  5. 5.
    Weinstein JR, Anderson S (2010) The aging kidney: physiological changes. Adv Chronic Kidney Dis 17:302–307CrossRefGoogle Scholar
  6. 6.
    Arking R (2006) The biology of aging. Oxford University Press, New YorkGoogle Scholar
  7. 7.
    Seal CJ, Parker DS (1991) Isolation and characterization of circulating low molecular weight peptides in steer, sheep and rat portal and peripheral blood. Comp Biochem Physiol B 99:679–685CrossRefGoogle Scholar
  8. 8.
    Brandsch M, Knutter I, Bosse-Doenecke E (2008) Pharmaceutical and pharmacological importance of peptide transporters. J Pharm Pharmacol 60:543–585CrossRefGoogle Scholar
  9. 9.
    Anderson CM, Thwaites DT (2010) Hijacking solute carriers for proton-coupled drug transport. Physiology (Bethesda Md) 25:364–377Google Scholar
  10. 10.
    Schwartz JB (2007) The current state of knowledge on age, sex, and their interactions on clinical pharmacology. Clin Pharmacol Ther 82:87–96CrossRefGoogle Scholar
  11. 11.
    Sengupta P (2013) The laboratory rat: relating its age with human’s. Int J Prev Med 4:624–630Google Scholar
  12. 12.
    Shen H, Smith DE, Yang T, Huang YG, Schnermann JB, Brosius III, FC (1999) Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney. Am J Physiol-Renal Physiol 276:F658–F665CrossRefGoogle Scholar
  13. 13.
    Biber J, Stieger B, Haase W, Murer H (1981) A high yield preparation for rat kidney brush border membranes. Different behaviour of lysosomal markers. Biochem Biophys Acta 647:169–176CrossRefGoogle Scholar
  14. 14.
    Donowitz M, Emmer E, McCullen J, Reinlib L, Cohen ME, Rood RP, Madara J, Sharp GW, Murer H, Malmstrom K (1987) Freeze-thaw and high-voltage discharge allow macromolecule uptake into ileal brush-border vesicles. Am J Physiol 252:G723–G735Google Scholar
  15. 15.
    Nakano M, Ito Y, Kohtani K, Mizuno T, Tauchi H (1985) Age-related change in brush borders of rat kidney cortex. Mech Ageing Dev 33:95–102CrossRefGoogle Scholar
  16. 16.
    Brown CD, King N, Simmons NL (1993) Co-expression of an anion conductance pathway with Na(+)-glucose cotransport in rat renal brush-border membrane vesicles. Pflugers Archiv Eur J Physiol 423:406–410CrossRefGoogle Scholar
  17. 17.
    Konopka K (1978) Differential effects of metal-binding agents on the uptake of iron from transferrin by isolated rat liver mitochondria. FEBS Lett 92:308–312CrossRefGoogle Scholar
  18. 18.
    Shen B, Jensen RG, Bohnert HJ (1997) Mannitol protects against oxidation by hydroxyl radicals. Plant Physiol 115:527–532CrossRefGoogle Scholar
  19. 19.
    Alghamdi OA, King N, Jones GL, Moens PDJ (2017) A new use of beta-Ala-Lys (AMCA) as a transport reporter for PEPT1 and PEPT2 in renal brush border membrane vesicles from the outer cortex and outer medulla. Biochim Biophys Acta 1860:960–964CrossRefGoogle Scholar
  20. 20.
    Sun Y, Yu H, Zheng D, Cao Q, Wang Y, Harris D, Wang Y (2011) Sudan black B reduces autofluorescence in murine renal tissue. Arch Pathol Lab Med 135:1335–1342CrossRefGoogle Scholar
  21. 21.
    Alghamdi OA, King N, Jones GL, Moens PDJ (2017) Kinetic measurements of Di- and tripeptide and peptidomimetic drug transport in different kidney regions using the fluorescent membrane potential-sensitive dye, DiS-C3-(3). J Membr Biol 250:641–649CrossRefGoogle Scholar
  22. 22.
    Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611–622CrossRefGoogle Scholar
  23. 23.
    Smith DE, Pavlova A, Berger UV, Hediger MA, Yang T, Huang YG, Schnermann JB (1998) Tubular localization and tissue distribution of peptide transporters in rat kidney. Pharm Res 15:1244–1249CrossRefGoogle Scholar
  24. 24.
    Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM (1981) Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 241:F85–F93Google Scholar
  25. 25.
    Tramonti G, Xie P, Wallner EI, Danesh FR, Kanwar YS (2006) Expression and functional characteristics of tubular transporters: P-glycoprotein, PEPT1, and PEPT2 in renal mass reduction and diabetes. Am J Physiol Renal Physiol 291:F972–F980CrossRefGoogle Scholar
  26. 26.
    Meissner B, Boll M, Daniel H, Baumeister R (2004) Deletion of the intestinal peptide transporter affects insulin and TOR signalling in Caenorhabditis elegans. J Biol Chem 279:36739–36745CrossRefGoogle Scholar
  27. 27.
    Abousaab A, Warsi J, Salker MS, Lang F (2016) β-Klotho as a negative regulator of the peptide transporters PEPT1 and PEPT2. Cell Physiol Biochem 40:874–882CrossRefGoogle Scholar
  28. 28.
    Amery A, Wasir H, Bulpitt C, Conway J, Fagard R, Lijnen P, Reybrouck T (1978) Aging and the cardiovascular system. Acta Cardiol 33:443–467Google Scholar
  29. 29.
    Pinto E (2007) Blood pressure and ageing. Postgrad Med J 83:109–114CrossRefGoogle Scholar
  30. 30.
    Turnheim K (2003) When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 38:843–853CrossRefGoogle Scholar
  31. 31.
    Takahashi K, Masuda S, Nakamura N, Saito H, Futami T, Doi T, Inui K (2001) Upregulation of H(+)-peptide cotransporter PEPT2 in rat remnant kidney. Am J Physiol Renal Physiol 281:F1109–F1116CrossRefGoogle Scholar
  32. 32.
    Buyse M, Berlioz F, Guilmeau S, Tsocas A, Voisin T, Peranzi G, Merlin D, Laburthe M, Lewin MJ, Roze C, Bado A (2001) PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine. J Clin Investig 108:1483–1494CrossRefGoogle Scholar
  33. 33.
    Hindlet P, Bado A, Farinotti R, Buyse M (2007) Long-term effect of leptin on H+-coupled peptide cotransporter 1 activity and expression in vivo: evidence in leptin-deficient mice. J Pharmacol Exp Ther 323:192–201CrossRefGoogle Scholar
  34. 34.
    Alteheld B, Evans ME, Gu LH, Ganapathy V, Leibach FH, Jones DP, Ziegler TR (2005) Alanylglutamine dipeptide and growth hormone maintain PepT1-mediated transport in oxidatively stressed Caco-2 cells. J Nutr 135:19–26CrossRefGoogle Scholar
  35. 35.
    Thamotharan M, Bawani SZ, Zhou X, Adibi SA (1999) Hormonal regulation of oligopeptide transporter pept-1 in a human intestinal cell line. Am J Physiol 276:C821–C826CrossRefGoogle Scholar
  36. 36.
    Ashida K, Katsura T, Motohashi H, Saito H, Inui K (2002) Thyroid hormone regulates the activity and expression of the peptide transporter PEPT1 in Caco-2 cells. Am J Physiol Gastrointest Liver Physiol 282:G617–G623CrossRefGoogle Scholar
  37. 37.
    Ashida K, Katsura T, Saito H, Inui K (2004) Decreased activity and expression of intestinal oligopeptide transporter PEPT1 in rats with hyperthyroidism in vivo. Pharm Res 21:969–975CrossRefGoogle Scholar
  38. 38.
    Doring F, Schmitt R, Bernhardt WM, Klapper M, Bachmann S, Daniel H, Groneberg DA (2005) Hypothyroidism induces expression of the peptide transporter PEPT2. Biol Chem 386:785–790CrossRefGoogle Scholar
  39. 39.
    Gabriely I, Ma XH, Yang XM, Rossetti L, Barzilai N (2002) Leptin resistance during aging is independent of fat mass. Diabetes 51:1016–1021CrossRefGoogle Scholar
  40. 40.
    Chang AM, Halter JB (2003) Aging and insulin secretion. Am J Physiol-Endocrinol Metabol 284:E7–E12CrossRefGoogle Scholar
  41. 41.
    Peeters RP (2008) Thyroid hormones and aging. HORMONES-ATHENS 7:28CrossRefGoogle Scholar
  42. 42.
    Aruoma OI, Laughton MJ, Halliwell B (1989) Carnosine, homocarnosine and anserine: could they act as antioxidants in vivo? Biochem J 264:863–869CrossRefGoogle Scholar
  43. 43.
    King N, McGivan JD, Griffiths EJ, Halestrap AP, Suleiman MS (2003) Glutamate loading protects freshly isolated and perfused adult cardiomyocytes against intracellular ROS generation. J Mol Cell Cardiol 35:975–984CrossRefGoogle Scholar
  44. 44.
    Kerksick C, Willoughby D (2005) The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress. J Int Soc Sports Nutr 2:38–44CrossRefGoogle Scholar
  45. 45.
    Haynes TE, Li P, Li X, Shimotori K, Sato H, Flynn NE, Wang J, Knabe DA, Wu G (2009) L-Glutamine or L-alanyl-L-glutamine prevents oxidant-or endotoxin-induced death of neonatal enterocytes. Amino Acids 37:131–142CrossRefGoogle Scholar
  46. 46.
    Tanida M, Shen J, Kubomura D, Nagai K (2010) Effects of anserine on the renal sympathetic nerve activity and blood pressure in urethane-anesthetized rats. Physiol Res 59:177–185Google Scholar
  47. 47.
    Nagai K, Tanida M, Niijima A, Tsuruoka N, Kiso Y, Horii Y, Shen J, Okumura N (2012) Role of L-carnosine in the control of blood glucose, blood pressure, thermogenesis, and lipolysis by autonomic nerves in rats: involvement of the circadian clock and histamine. Amino Acids 43:97–109CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.School of Science and TechnologyUniversity of New EnglandArmidaleAustralia
  2. 2.School of Biomedical SciencesUniversity of PlymouthPlymouthUK
  3. 3.Discipline of Pathology, Sydney Medical School, Charles Perkins CentreThe University of SydneySydneyAustralia
  4. 4.Department of Biological Sciences, Faculty of Science, Centre for Science and Medical ResearchUniversity of JeddahJeddahSaudi Arabia

Personalised recommendations